Related Experiment Video
Updated: Aug 13, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Abundant hypermethylation of SOCS-1 in clinically silent pituitary adenomas
Rolf Buslei1, Jürgen Kreutzer, Bernd Hofmann
1Department of Neuropathology, Friedrich-Alexander University of Erlangen-Nuremberg, Krankenhausstrasse 8-10, 91054, Erlangen, Germany. rolf.buslei@neuropatho.imed.uni-erlangen.de
Abstract:
Janus kinase (JAK)/signal transducers and activators of transcription (STAT) cascade are required for cytokines, growth factors, G-proteins and hormones (growth hormone and prolactin). Gatekeepers in this pathway are the suppressor of cytokine signalling (SOCS) family of proteins. Their expression level is epigenetically regulated by DNA methylation. We have investigated the CpG island methylation status of SOCS-1 in a cohort of pituitary adenomas (PA; n=57), craniopharyngiomas (CP; n=30) and normal pituitary tissue (NP; n=11) using methylation sensitive single-strand conformation polymorphism analysis (MS-SSCP) and direct sequencing. SOCS-1 hypermethylation was identified in 51% (29/57) of surgical specimens obtained from PA patients. 83% of these tumours were clinically silent. In contrast, no methylation of SOCS-1 was observed in CPs or NPs. Quantitative real-time PCR and western blot analysis confirmed reduced SOCS-1 expression in the majority of pituitary adenomas. The data is compatible with epigenetic silencing of the SOCS-1 gene and constitutive activation of the JAK-STAT pathway in PA. This appears to contribute particularly to those tumours characterized by a hormone-inactive status.
Insights
Epigenetic silencing of SOCS-1 via DNA methylation is common in pituitary adenomas (PA), leading to Janus kinase (JAK)/STAT pathway activation, particularly in hormone-inactive tumors.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- The Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway is crucial for cellular signaling.
- Suppressor of cytokine signaling (SOCS) proteins, including SOCS-1, regulate this pathway.
- Epigenetic regulation, specifically DNA methylation, influences SOCS gene expression.
Purpose of the Study:
- To investigate the CpG island methylation status of SOCS-1 in pituitary adenomas (PA), craniopharyngiomas (CP), and normal pituitary (NP) tissues.
- To correlate SOCS-1 methylation with gene expression and clinical characteristics of pituitary tumors.
Main Methods:
- Methylation-sensitive single-strand conformation polymorphism (MS-SSCP) analysis and direct sequencing were used to assess SOCS-1 methylation.
- Quantitative real-time PCR and western blot analysis were employed to measure SOCS-1 expression levels.
Main Results:
- SOCS-1 hypermethylation was detected in 51% of pituitary adenomas, predominantly in clinically silent tumors.
- No SOCS-1 methylation was found in craniopharyngiomas or normal pituitary tissues.
- Reduced SOCS-1 expression was confirmed in the majority of pituitary adenomas, correlating with hypermethylation.
Conclusions:
- Epigenetic silencing of SOCS-1 through DNA hypermethylation contributes to constitutive JAK-STAT pathway activation in pituitary adenomas.
- This epigenetic alteration appears particularly relevant in the pathogenesis of hormone-inactive pituitary adenomas.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Pleiotropy
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Cushing Syndrome I: Introduction

